Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008 - a retrospective study of hospital records to assess the sensitivity of surveillance

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Jenssen, Gaute R ^a,b   Hovland, Eirik ^a,b   Bjerre, Anna ^c   Bangstad, Hans Jacob ^c   Nygard, Karin ^a   Vold, Line ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Enterohaemorrhagic E. coli EHEC; Epidemiology; Haemolytic uraemic syndrome; Shiga toxin producing E. coli STEC; Surveillance

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIARRHEA; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ESCHERICHIA COLI INFECTION; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROBIOLOGY; NORWAY; PATHOGENESIS; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY ANALYSIS; SEX DIFFERENCE; COMMUNICABLE DISEASES; EPIDEMIC; EPIDEMIOLOGY; ESCHERICHIA COLI INFECTIONS; GENETICS; HEALTH SURVEY; HEMOLYTIC-UREMIC SYNDROME; ISOLATION AND PURIFICATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DIARRHEA; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HOSPITAL RECORDS; HUMANS; INCIDENCE; INFANT; MALE; NORWAY; PUBLIC HEALTH SURVEILLANCE; RETROSPECTIVE STUDIES; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 84901656177     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-265     Document Type: Article

References (33)

1. Kaplan BS, Meyers KE, Schulman SL. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 1998, 9:1126-1133.
2. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006, 70:423-431.
3. European Centre for Disease Prevention and Control Basic facts on Escherichia Coli (E. Coli). http://www.ecdc.europa.eu/en/healthtopics/escherichia_coli/basic_facts/Pages/basic_facts.aspx, European Centre for Disease Prevention and Control.
4. European Food Safety Authority, European Centre for Disease Prevention and Control The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks. 2009, Available from: http://www.efsa.europa.eu/efsajournal, European Food Safety Authority, European Centre for Disease Prevention and Control.
5. Bitzan M, Ludwig K, Klemt M, Konig H, Buren J, Muller-Wiefel DE. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a central European, multicentre study. Epidemiol Infect 1993, 110:183-196. 10.1017/S0950268800068102, 2272264, 8472763.
6. Lynn RM, OBrien SJ, Taylor CM, Adak GK, Chart H, Cheasty T, Coia JE, Gillespie IA, Locking ME, Reilly WJ, Smith HR, Waters A, Willshaw GA. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005, 11:590-596. 10.3201/eid1104.040833, 3320351, 15829199.
7. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002, 186:493-500. 10.1086/341940, 12195376.
8. Schifferli A, Von Vigier RO, Fontana M, Sparta G, Schmid H, Bianchetti MG, Rudin C. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003. Eur J Pediatr 2010, 169:591-598. 10.1007/s00431-009-1079-9, 19830454.
9. Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, Trachtman H. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 2004, 43:976-982. 10.1053/j.ajkd.2004.02.010, 15168377.
10. Caprioli A, Luzzi I, Rosmini F, Pasquini P, Cirrincione R, Gianviti A, Matteucci MC, Rizzoni G. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group. J Infect Dis 1992, 166:154-158. 10.1093/infdis/166.1.154, 1607689.
11. Tozzi AE, Caprioli A, Minelli F, Gianviti A, De Petris L, Edefonti A, Montini G, Ferretti A, De Palo T, Gaido M, Rizzoni G. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003, 9:106-108. 10.3201/eid0901.020266, 2873761, 12533290.
12. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
13. The European Commission Case Definitions of Communicable Diseases Available from: http://eur-lex.europa.eu/, The European Commission.
14. Espie E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, De Valk H. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J 2008, 27:595-601. 10.1097/INF.0b013e31816a062f, 18520972.
15. Proulx F, Sockett P. Prospective surveillance of Canadian children with the haemolytic uraemic syndrome. Pediatr Nephrol 2005, 20:786-790. 10.1007/s00467-005-1843-7, 15834619.
16. Elliott EJ, Robins-Browne RM, OLoughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001, 85:125-131. 10.1136/adc.85.2.125, 1718875, 11466187.
17. March SB, Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 1986, 23:869-872. 268739, 3519658.
18. Norwegian Institute of Pulic Health E. coli-enteritis (including EHEC-infection and HUS) [In Norwegian] http://www.fhi.no/artikler/?id=82709], Norwegian Institute of Pulic Health.
19. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002, 185:74-84. 10.1086/338115, 11756984.
20. Kemper MJ. Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective. Pediatr Nephrol 2012, 27:161-164. 10.1007/s00467-011-2067-7, 22160440.
21. Schimmer B, Nygard K, Eriksen HM, Lassen J, Lindstedt BA, Brandal LT, Kapperud G, Aavitsland P. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect Dis 2008, 8:41. 10.1186/1471-2334-8-41, 2335110, 18387178.
22. Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Naess PA, Bangstad HJ. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med 2011, 19:44. 10.1186/1757-7241-19-44, 3160365, 21798000.
23. Karama M, Gyles CL. Methods for genotyping verotoxin-producing Escherichia coli. Zoonoses Public Health 2010, 57:447-462. 10.1111/j.1863-2378.2009.01259.x, 19912610.
24. Rivero MA, Padola NL, Etcheverria AI, Parma AE. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina]. Medicina (B Aires) 2004, 64:352-356.
25. Prado JV, Cavagnaro SMF. [Hemolytic uremic syndrome associated to shigatoxin producing Escherichia coli in Chilean children: clinical and epidemiological aspects]. Rev Chilena Infectol 2008, 25:435-444.
26. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 2002, 155:941-948. 10.1093/aje/155.10.941, 11994234.
27. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991, 13:60-98.
28. Pollock KG, Locking ME, Beattie TJ, Maxwell H, Ramage I, Hughes D, Cowieson J, Allison L, Hanson M, Cowden JM. Sorbitol-fermenting Escherichia coli O157, Scotland. Emerg Infect Dis 2010, 16:881-882. 10.3201/eid1605.091919, 2954015, 20409394.
29. Vold L, Klungseth Johansen B, Kruse H, Skjerve E, Wasteson Y. Occurrence of shigatoxinogenic Escherichia coli O157 in Norwegian cattle herds. Epidemiol Infect 1998, 120:21-28. 10.1017/S0950268897008364, 2809345, 9528814.
30. Johnsen G, Wasteson Y, Heir E, Berget OI, Herikstad H. Escherichia coli O157:H7 in faeces from cattle, sheep and pigs in the southwest part of Norway during 1998 and 1999. Int J Food Microbiol 2001, 65:193-200. 10.1016/S0168-1605(00)00518-3, 11393688.
31. Urdahl AM, Bruheim T, Cudjoe K, Hofshagen M, Hopp P, Johannessen G, Sunde M. Survey of E. coli in Sheep [In Norwegian]. [http://www.vetinst.no/Publikasjoner/Rapportserie/Rapportserie-2009/5-2009-Kartlegging-av-E.-coli-hos-sau-sluttrapport].
32. Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, Slack MP, Van't Hoff W, Dillon MJ, Taylor CM, Tullus K. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007, 151:140-144. 10.1016/j.jpeds.2007.03.055, 17643764.
33. Veesenmeyer AF, Edmonson MB. Trends in US Hospital Stays for Streptococcus pneumoniae-associated Hemolytic Uremic Syndrome. Pediatr Infect Dis J 2013, 32:731-735. 10.1097/INF.0b013e31828b31c8, 23838775.